1-19 of 19
Radovan Vrhovac
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correlation of Baseline Gene Mutations With Quizartinib Efficacy in Patients With FLT3 -ITD-Positive Newly Diagnosed Acute Myeloid Leukemia in the Phase 3 QuANTUM-First Trial

Mark J. Levis, Pau Montesinos, Hee-Je Kim, Radovan Vrhovac, Elzbieta Patkowska, Pavel Zak, Po-Nan Wang, Jorge E. Cortes, Mikkael A. Sekeres, Hervé Dombret, Sergio Amadori, Jianxiang Wang, Richard F. Schlenk, Alexander E. Perl, Mitsuhiro Yazawa, Jaime E. Connolly Rohrbach, Venkat Thodima, Ken C. N. Chang, Li Liu, Karima Imadalou, Akash Nahar, Kristy Burns, Harry P. Erba
Journal: Blood
Blood (2024) 144 (Supplement 1): 848.
https://doi.org/10.1182/blood-2024-203303
Published: 2024
Journal Articles

Decitabine in older patients with AML: quality of life results of the EORTC-GIMEMA-GMDS-SG randomized phase 3 trial

Clinical Trials & Observations
Fabio Efficace, Michal Kicinski, Corneel Coens, Stefan Suciu, Walter J. F. M. van der Velden, Richard Noppeney, Sylvain Chantepie, Laimonas Griskevicius, Andreas Neubauer, Ernesta Audisio, Mario Luppi, Stephan Fuhrmann, Robin Foà, Martina Crysandt, Gianluca Gaidano, Radovan Vrhovac, Adriano Venditti, Eduardus F. M. Posthuma, Anna Candoni, Frédéric Baron, Olivier Legrand, Andrea Mengarelli, Paola Fazi, Marco Vignetti, Anne Giraut, Pierre W. Wijermans, Gerwin Huls, Michael Lübbert
Journal: Blood
Blood (2024) 144 (5): 541–551.
https://doi.org/10.1182/blood.2023023625
Published: 2024
Includes: Supplemental data
Journal Articles

Outcomes in Chemotherapy-Ineligible Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Venetoclax Plus Azacitidine: A Pooled Analysis

Adriano Venditti, Jing-Zhou Hou, Pierre Fenaux, Brian A. Jonas, Radovan Vrhovac, Pau Montesinos, Jacqueline S. Garcia, David Rizzieri, Michael J Thirman, Stanley Kotey, Jalaja Potluri, Mazaher Dhalla, Vinod Pullarkat
Journal: Blood
Blood (2023) 142 (Supplement 1): 2886.
https://doi.org/10.1182/blood-2023-182045
Published: 2023
Journal Articles

Quantum-First Trial: FMS-like Tyrosine Kinase 3-Internal Tandem Duplication ( FLT3 -ITD)-Specific Measurable Residual Disease (MRD) Clearance Assessed through Induction (IND) and Consolidation (CONS) Is Associated with Improved Overall Survival (OS) in Newly Diagnosed (nd) FLT3 -ITD+ AML Patients (pts)

Alexander Perl, Harry P. Erba, Pau Montesinos, Radovan Vrhovac, Elzbieta Patkowska, Heeje Kim, Pavel Zak, Po-Nan Wang, Jaime E Rohrbach, Ken C N Chang, Li Liu, Yasser Mostafa Kamel, Karima Imadalou, Arnaud Lesegretain, Jorge Cortes, Mikkael A. Sekeres, Hervé Dombret, Sergio Amadori, Jianxiang Wang, Richard F Schlenk, Mark J. Levis
Journal: Blood
Blood (2023) 142 (Supplement 1): 832.
https://doi.org/10.1182/blood-2023-186785
Published: 2023
Journal Articles

10-Day Decitabine Versus Intensive Chemotherapy Followed By Transplantation in Fit AML Patients Aged ≥60 Years: Health-Related Quality of Life Outcomes of the Randomized Phase III Trial AML21 of the EORTC Leukemia Group, Gimema, Celg, and Gmds-SG

Fabio Efficace, Gerwin A. Huls, Michal Kicinski, Walter JFM Van Der Velden, Richard Noppeney, Sylvain Chantepie, Laimonas Griskevicius, Andreas Neubauer, Ernesta Audisio, Mario Luppi, Stephan Fuhrmann, Robin Foà, Martina Crysandt, Gianluca Gaidano, Radovan Vrhovac, Adriano Venditti, Eduardus F.M. Posthuma, Anna Candoni, Frederic Baron, Olivier Legrand, Andrea Mengarelli, Marco Vignetti, Anne Giraut, Corneel Coens, Stefan Suciu, P.W. Wijermans, Michael Luebbert
Journal: Blood
Blood (2022) 140 (Supplement 1): 1281–1283.
https://doi.org/10.1182/blood-2022-166544
Published: 2022
Journal Articles

Application of a Validated Composite Comorbidity Score Measuring Both Fitness and Cytogenetic Risk to Assess Outcomes in 1L AML Patients Who Received Venetoclax Plus Azacitidine in Viale-A

Adriano Venditti, Jing-Zhou Hou, Pierre Fenaux, Brian A. Jonas, Radovan Vrhovac, Pau Montesinos, Jacqueline S. Garcia, David Rizzieri, Michael J. Thirman, Melissa Montez, Yingyi Liu, John Katsetos, Jalaja Potluri, Catherine Miller, Vinod A. Pullarkat
Journal: Blood
Blood (2022) 140 (Supplement 1): 8993–8995.
https://doi.org/10.1182/blood-2022-158500
Published: 2022
Journal Articles

Impact of Allogeneic Hematopoietic Cell Transplantation in First Complete Remission in Addition to FLT3 Inhibition with Quizartinib in Acute Myeloid Leukemia with FLT3 -Internal Tandem Duplication: Results from the Quantum-First Trial

Richard F. Schlenk, Pau Montesinos, Antonio Romero-Aguilar, Radovan Vrhovac, Elżbieta Patkowska, Hee-Je Kim, Pavel Zak, Po-Nan Wang, James Hanyok, Li Liu, Yasser Mostafa Kamel, Aziz Benzohra, Arnaud Lesegretain, Jorge E. Cortes, Mikkael A. Sekeres, Hervé Dombret, Sergio Amadori, Jianxiang Wang, Alexander E. Perl, Mark J. Levis, Harry P. Erba
Journal: Blood
Blood (2022) 140 (Supplement 1): 2130–2132.
https://doi.org/10.1182/blood-2022-169011
Published: 2022
Journal Articles

Quantum-First Trial: FLT3 -ITD-Specific MRD Clearance Is Associated with Improved Overall Survival

Mark J. Levis, Harry P. Erba, Pau Montesinos, Radovan Vrhovac, Elzbieta Patkowska, Heeje Kim, Pavel Zak, Po-Nan Wang, Jaime E. Connolly Rohrbach, Ken CN Chang, James Hanyok, Li Liu, Yasser Mostafa Kamel, Arnaud Lesegretain, Jorge E. Cortes, Mikkael A. Sekeres, Hervé Dombret, Sergio Amadori, Jianxiang Wang, Richard F. Schlenk, Alexander Perl
Journal: Blood
Blood (2022) 140 (Supplement 1): 546–548.
https://doi.org/10.1182/blood-2022-162739
Published: 2022
Journal Articles

Use of G-CSF for Bone Marrow Graft Mobilization Increases NK Cell, Treg and iNKT Cell Graft Content, Possibly Lowering the Risk of Severe Acute Gvhd and Chronic Gvhd in HLA-Haploidentical Bone Marrow Transplantation (BMT) with Post-Transplantation Cyclophosphamide (PT-CY)

Nadira Durakovic, Antonija Babić, Lana Desnica, Zinaida Peric, Ranka Serventi Seiwerth, Drago Batinić, Radovan Vrhovac
Journal: Blood
Blood (2022) 140 (Supplement 1): 7558–7559.
https://doi.org/10.1182/blood-2022-165445
Published: 2022
Journal Articles

Outcome of Patients with Hodgkin Lymphoma Treated with Brentuximab Vedotin for Relapse after Autologous Stem Cell Transplant: A Retrospective Analysis of the LWP-EBMT

Nikesh Dhiraj Chavda, MBBChir, Stephen Robinson, MBBS, PhD BSc, Ariane Boumendil, Irma Khvedelidze, Hervé Finel, Saad Akhtar, MD, M S Rauf, MD, Nadira Durakovic, MD, Radovan Vrhovac, MD PhD, Maurizio Musso, MD, Pauline Brice, Mutlu Arat, MD, Didier Blaise, MD PhD, Matthew P. Collin, MD PhD, Joanna Romejko-Jarosinska, MD PhD, Aspasia Stamatoullas, MD, Zubeyde Nur Ozkurt, MD, Tadeusz Robak, MD, Björn E Wahlin, MD PhD, Keith Wilson, FRCPath, MRCP, MBBS, Eleonora Alma, Rocco Pastano, Luca Castagna, MD, Ali Bazarbachi, MD PhD, Hervé Ghesquieres, MD PhD, Andrei Colita, MD PhD, Silvia Montoto, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4018.
https://doi.org/10.1182/blood-2019-131410
Published: 2019
Journal Articles

Severe Ocular Graft-Versus-Host Disease Successfully Treated with Amniotic Membrane Transplantation - Case Series

Zinaida Peric, MD PhD, Ivan Skegro, MD, Nadira Durakovic, MD, Lana Desnica, MD PhD, Ranka Serventi-Seiwerth, MD, Drazen Pulanic, MD PhD, Igor Petricek, MD PhD, Steven Z. Pavletic, MD, Radovan Vrhovac, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3270.
https://doi.org/10.1182/blood.V130.Suppl_1.3270.3270
Published: 2017
Journal Articles

The Impact of Cytogenetic Clonality on Outcomes in Younger Acute Myeloid Leukemia Patients: Results on 1290 Patients Included in the EORTC/Gimema AML-10 and AML-12 Trials

Frederic Baron, Marian Stevens-Kroef, PhD, Michal Kicinski, Giovanna Meloni, Petra Muus, Jean-Pierre Marie, Constantijn J.M. Halkes, Xavier Thomas, MD, Radovan Vrhovac, MD PhD, Crescenza Pasciolla, Francois Lefrere, Sr., Simona Sica, Marco Mancini, Adriano Venditti, MD, Anne Hagemeijer, Heiko Becker, Joop H. Jansen, Sergio Amadori, MD, T. M. M de Witte, MD PhD, Roelof Willemze, Stefan Suciu
Journal: Blood
Blood (2017) 130 (Supplement 1): 1385.
https://doi.org/10.1182/blood.V130.Suppl_1.1385.1385
Published: 2017
Journal Articles

Impact of the Type of Anthracycline and of Allogeneic Stem Cell Transplantation in the Treatment of Younger Acute Myeloid Leukemia Patients: Long-Term Follow-up of the EORTC-Gimema AML-10 Trial

Frederic Baron, Fabio Efficace, PhD, Laura Cannella, Franco Mandelli, Petra Muus, Silvia Maria Trisolini, Constantijn J.M. Halkes, Paola Fazi, Marco Vignetti, Jean-Pierre Marie, Patrizia Chiusolo, Walter JFM Van Der Velden, Edoardo La Sala, Umberto Vitolo, Xavier Thomas, MD, Francois Lefrere, Sr., Francesco Di Raimondo, MD, Jean-Henri Bourhis, Giorgina Specchia, Jose E. Guimaraes, MD PhD, Bernardino Allione, Radovan Vrhovac, MD PhD, Felicetto Ferrara, Marian Stevens-Kroef, PhD, Roelof Willemze, Sergio Amadori, MD, Theo de Witte, Stefan Suciu
Journal: Blood
Blood (2017) 130 (Supplement 1): 3850.
https://doi.org/10.1182/blood.V130.Suppl_1.3850.3850
Published: 2017
Journal Articles

Impact of Induction Regimen and of Allogeneic Hematopoietic Cell Transplantation on the Outcome in Younger Adults Patients with Acute Myeloid Leukemia with a Monosomal Karyotype: Results from the EORTC/Gimema AML-10 and AML-12 Trials

Frederic Baron, MD PhD, Marian Stevens-Kroef, PhD, Giovanna Meloni, MD, Petra Muus, MD PhD, Jean-Pierre Marie, MD, Constantijn J.M. Halkes, MD PhD, Xavier Thomas, MD PhD, Radovan Vrhovac, MD PhD, Giorgina Specchia, MD, Francois Lefrere, Sr., MD, Simona Sica, Marco Mancini, MD, Adriano Venditti, MD, Anne Hagemeijer, MD, Joop H. Jansen, PhD, Sergio Amadori, MD, Theo de Witte, MD, Roelof Willemze, MD PhD, Stefan Suciu, PhD
Journal: Blood
Blood (2016) 128 (22): 2847.
https://doi.org/10.1182/blood.V128.22.2847.2847
Published: 2016
Journal Articles

Implementation of NIH Criteria for Standardization of Chronic Graft-Versus-Host Disease in Croatia: Two-Year Experience

Lana Desnica, MD, Drazen Pulanic, MD PhD, Ranka Serventi Seiwerth, MD, Nikolina Matic, RN, Marinka Mravak Stipetic, DMD,PhD, Ervina Bilic, MD PhD, Romana Ceovic, MD PhD, Dina Ljubas Kelecic, mr. pharm., Ljubica Rajic, MD PhD, Ernest Bilic, MD PhD, Nadira Durakovic, MD PhD, Zinaida Peric, MD PhD, Tajana Klepac Pulanic, MD, Tamara Vukic, MD, Igor Petricek, MD PhD, Davorka Dusek, MD, Ines Bojanic, MD PhD, Ema Prenc, Mrs., Iva Ozana Prah, PhD, Magdalena Grce, PhD, Renata Zadro, MD PhD, Drago Batinic, MD PhD, Radovan Vrhovac, MD PhD, Steven Z. Pavletic, MD, Damir Nemet, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5580.
https://doi.org/10.1182/blood.V126.23.5580.5580
Published: 2015
Journal Articles

Post-Thaw Viability of Cryopreserved Hematopoietic Progenitor Cell Grafts Influences Patients' Predisposition towards Infectious Complications in the Post-Transplant Period.

Radovan Vrhovac, Zinaida Peric, Silvana Jurenec, Ika Kardum-Skelin, Biljana Jelic-Puskaric, Zoran Siftar, Jasna Mesaric, Hrvoje Minigo, Branimir Jaksic
Journal: Blood
Blood (2009) 114 (22): 4666.
https://doi.org/10.1182/blood.V114.22.4666.4666
Published: 2009
Journal Articles

Febrile Neutropenia Following Autologous Stem Cell Transplantation in Patients with Lymphoma

Radovan Vrhovac, Zinaida Peric, Matko Kalac, Alen Ostojic, Visnja Kovacevic, Suzana Bukovski-Simonoski, Arjana Tambic-Andrasevic, Hrvoje Minigo, Branimir Jaksic
Journal: Blood
Blood (2008) 112 (11): 4379.
https://doi.org/10.1182/blood.V112.11.4379.4379
Published: 2008
Journal Articles

More on prognostic significance of FLT3/ITD size in acute myeloid leukemia (AML)

Rajko Kusec, Ozren Jaksic, Slobodanka Ostojic, Ika Kardum-Skelin, Radovan Vrhovac, Branimir Jaksic
Journal: Blood
Blood (2006) 108 (1): 405–406.
https://doi.org/10.1182/blood-2005-12-5128
Published: 2006
Journal Articles

Prognostic Significance of the Cell Cycle Inhibitor p27 Kip1 in Chronic B-Cell Lymphocytic Leukemia

Radovan Vrhovac, Alain Delmer, Ruoping Tang, Jean-Pierre Marie, Robert Zittoun, Florence Ajchenbaum-Cymbalista
Journal: Blood
Blood (1998) 91 (12): 4694–4700.
https://doi.org/10.1182/blood.V91.12.4694
Published: 1998